BUY Supriya Lifescience Limited — Kush Bohra
byKush BohraHorizon: NA (inferred Swing (≤2wk))29 Sept 2026via NDTV Profit
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Supriya Lifescience Limited Approves Final Dividend for the Financial Year Ended March 31, 2026
NewsGoogle News·25 Sept · 4d ago
1 advisor has an active short-term BUY call on this stock
Advisor consensus · adjacent horizon·6 Jul · 3mo ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Supriya Lifescience
- BUY — Madhu Bansal11 Nov 2026 · ~2 weeks · target ₹725 · SL hit
- BUY — Madhu Bansal29 Sept 2026 · ~2 weeks · target ₹1,078 · SL hit
- BUY — Om Mehra, SAMCO Securities28 Sept 2026 · ~2 weeks · target ₹1,060 · SL hit
- BUY — Dharmesh Shah, ICICI Securities24 Sept 2026 · ~2 weeks · target ₹1,011 · Target hit
- BUY — Om Mehra, SAMCO Securities21 Sept 2026 · ~2 weeks · target ₹980 · Target hit
More from Kush Bohra
- BUY Apollo Micro Systems13 Nov 2026 · ~2 weeks · target ₹500 · Active
- BUY Pine Labs13 Nov 2026 · ~2 weeks · target ₹183 · Active
- BUY Varroc Engineering13 Nov 2026 · ~2 weeks · target ₹865 · Active
- BUY Allied Blenders and Distillers13 Nov 2026 · Same day · target ₹780 · Expired
- BUY Pricol13 Nov 2026 · Same day · target ₹750 · Expired

